U.S. Markets open in 9 hrs 27 mins

(GERN,STEM)

. Currency in USD
Add to watchlist
Full screen
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    ETFs with exposure to Geron Corp. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Geron Corp. Here are 5 ETFs with the largest exposure to GERN-US. Comparing the performance and risk of Geron Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Geron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cube2 days ago

    Geron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Geron Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Geron Corp. – BioTime, Inc., Gilead Sciences, Inc., CTI BioPharma Corp., Bio-Techne Corporation, Microbot Medical Inc, Stemline Therapeutics, Inc., Immunomedics, Inc. and Incyte Corporation (BTX-US, GILD-US, CTIC-US, TECH-US, MBOT-US, ... Read more (Read more...)

  • The Key Reason Incyte Corporation Added $850 Million in Market Cap in August
    Motley Fool16 days ago

    The Key Reason Incyte Corporation Added $850 Million in Market Cap in August

    An update on bariticinib's review timeline has Wall Street rightly excited.